A new path to medicine.

aTyr is harnessing newly discovered pathways in immunology. Our lead product candidate, ATYR1923, is entering Phase 1b/2a clinical development for the treatment of pulmonary sarcoidosis.

Learn More

© 2007 - 2018   aTyr Pharma.   Legal   Privacy Policy